SANOFI SPON ADR ECH REP 0.5 ORD SHS (NASDAQ: SNY)

Overview
current price
$45.39
$45.39
change
-0.72 | -1.56%
-0.72 | -1.56%
Yesterday's Close
46.11
open
45.47
volume
4.36 M
30d. avg volume.
1.72 M
1 day
45.22 - 45.71
52 weeks
42.63 - 57.82
p/e
24.79
beta
0.6066
market cap
116.64 B
dividend yield
3.21%
Industry
-
News and Commentary
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Mar... After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-declining trend.
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants Friday, The Centers for Disease Control and Prevention recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborns from severe R...
Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports The Medicines and Healthcare Products Regulatory Agency (MHRA), the U.K.'s drug regulatory authority, is reportedly scrutinizing a category of drugs used in diabetes medication a...
First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California The initial U.S. court trial concerning the antacid medication Zantac is slated to commence on November 13 in a state court in California, as stated by a lawyer representing the...
GSK Confidentially Settles First Zantac-Associated Cancer Lawsuit Due For US Trial Next Month GSK plc (GSK 
Johnson & Johnson's Kenvue Valued at $40 Billion Ahead of IPO Johnson & Johnson's (JNJ
Fourth COVID Vaccine? Sanofi, GSK Submit Data Seeking Regulatory Approval After Several Setbacks French drugmaker Sanofi (SNY
Walmart to Offer Cheaper Insulin to Uninsured Americans More than 34 million people in the U.S. have diabetes, and a prescription for the insulin needed to treat this potentially deadly condition costs an average of
Market Update: S&P 500 and Nasdaq Reach Another Fresh Closing High Both the S&P 500 and Nasdaq secured fresh closing highs on Tuesday on the back of bullish consumer confidence and housing data.Here's how the market...
F.D.A. Will Not Require Long Clinical Trials for Coronavirus Vaccines Modified for Variant Strains The U.S. Food and Drug Administration (F.D.A.) announced on Monday that modified coronavirus vaccines developed to protect against new, emerging variants of SARS-CoV-2 may be aut...
StockTwits
StockTwits

Join now and unlock premium features